Navigation Links
NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Date:9/10/2007

.5 million relating to the Claims Payable Error as defined and discussed above offsets the $1.5 million relating to the Rebate Error as noted above. Primarily due to changes in our customer mix, gross profit as a percentage of revenue, or gross margin, for the fiscal year ended June 30, 2007 increased to 12.9 percent as compared to 10.6 percent for the same period last year.

Gross profit per adjusted prescription for the fiscal year ended June 30, 2007 increased to $3.53 as compared to $2.76 for the same period last year.

For the fiscal year ended June 30, 2007, SG&A expenses increased $11.6 million or 15.3 percent, from $75.9 million to $87.5 million for the same period last year. This increase is primarily the result of (i) $5.8 million net increase in compensation related costs, inclusive of a $2.3 million increase in one-time termination benefits primarily related to our senior management changes, (ii) $2.9 million increase in professional fees and insurance, primarily related to the review of various financial transactions in conjunction with the filings of our Quarterly Report on Form 10-Q for the periods ended December 31, 2006 and September 30, 2006, settlements of various legal proceedings, as well as an increase in our insurance premiums, (iii) $1.2 million increase in IT related costs, which includes a $657,000 impairment loss related to the cancellation of various capitalized projects, (iv) $1.9 million increase in bad debt expense (inclusive of the $831,000 Claims Payable Error as noted above), of which $1.2 million was incurred during the fourth quarter of fiscal 2007, and (v) $384,000 of net increases in other SG&A expenses. These increases were offset by $584,000 related to the Lease Error as defined and discussed above.

NMHC's effective tax rate was 92.9 percent for the fiscal year ended June 30, 2007, as compared to 42.1 percent for the same period last year. The increase in the effective tax rate primarily resulted from lower pre
'/>"/>

SOURCE National Medical Health Card Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- ...d asthma can have bad reactions to certain holiday...ent sneezing and wheezing, according to the Americ...I). , Those who are allergic to live evergreens ma...oth live and artificial trees can trigger symptoms...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...arguments by critics, a University of Utah-led stu...e in Oregon and the Netherlands did not result in ...rly, poor, women, minorities, uninsured, minors, c...ide at elevated rates. , Fears about the impact ...
...f., Sept. 26 AARP asks,Governor Schwarzenegger to... children currently enrolled in the State Children...e of Representatives passed a bill,which would exp...xpand the program too much. In a letter to the ad...
...exclusive North American rights to bepotastine for...RVINE, Calif., Sept. 26 ISTA,Pharmaceuticals, Inc...d,exclusive North American rights to nasal dosage ...ve North American rights,to ophthalmic allergy app...
..., Sept. 26 While the fall season has,officially b... parasites,lingers with the season,s warm weather....animal health news, offers pet owners these facts ...ronments and feed on the blood of their hosts....
...on of no causal link disputes its own data while s... spotlight conflicts of interest, NIXA, Mo., Sept...hat a CDC study of only 1047 participants, low,com... public. They question how such a poor quality stu...
...t antibody explains why even ,matched, organs get ...y News) -- Researchers say a newly discovered immu...ections and may explain why otherwise well-matched...author and assistant professor of internal medicin...
Other Medicine News:Health News:Doctor-aided suicide: No slippery slope 2Health News:Doctor-aided suicide: No slippery slope 3Health News:Doctor-aided suicide: No slippery slope 4Health News:AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill 2Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 3Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 4Health News:ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 5Health News:Summer Temperatures Linger, Extend Threat of Parasites 2Health News:CDC Study Links Thimerosal in Vaccines to Motor/Phonic Tics and Deficits in Attention, Behavior Control, Verbal IQ 2Health News:Scientists Spot Key to Kidney Transplant Success 2Health News:Scientists Spot Key to Kidney Transplant Success 3Health News:Scientists Spot Key to Kidney Transplant Success 4
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4National Greatness Contest Winners Announced 58136 1National Greatness Contest Winners Announced 58136 2National Greatness Contest Winners Announced 58136 3MedShape Solutions Inc Announces First FDA cleared Shape Memory PEEK Device 3B Closing of 2410M Equity Offering 14230 1MedShape Solutions Inc Announces First FDA cleared Shape Memory PEEK Device 3B Closing of 2410M Equity Offering 14230 2Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 1Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 2Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 3Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 4Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 5
...-Dose Protection Observed Prior to or Up to 24 Hou...y 24, 2007 /PRNewswire/ -- Targanta,Therapeutics C...nt,study demonstrating oritavancin as a potential ...s, the bacterium which causes anthrax,an acute in...etic,lipoglycopeptide antibiotic for the treatment...
...EY HEIGHTS, N.J.--(BUSINESS WIRE)--May 24, 2007 - ...AQ: CYCCP) announced today,that it will report res...abine (CYC682), a novel orally-available nucleosid...yelodysplastic syndromes,(MDS), at the American So... at McCormick Place in Chicago. Details of the pre...
Other Medicine Technology:Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 2Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 3Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 4Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study,Results at the American Society of Clinical Oncology Annual Meeting 2Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study,Results at the American Society of Clinical Oncology Annual Meeting 3
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: